No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Crizotinib
-
Drug Resistance, Neoplasm / genetics*
-
Fatal Outcome
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / genetics
-
Liver Neoplasms / secondary
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Mutation / genetics*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / therapeutic use*
-
Pyridines / therapeutic use*
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
-
Receptor Protein-Tyrosine Kinases / genetics*
Substances
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases